Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
Login My Member Benefits Archives Research Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • Angel Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: Abbott Laboratories, Affiliated Computer Services Inc., American Securities, Crucell, Dell, Don Miller, Dow Jones Industrial Average, GenTek, Investment Company Institute, M&A, Nasdaq Composite Index, Oracle, Perot Systems, S&P 500, Solvay SA, Sun Microsystems, Xerox

Flurry of Mergers and Acquisitions Drives Stock Market Rally

By Don Miller, Contributing Writer, Money Morning • September 28, 2009

View Comments

Start the conversation

Comment on This Story Click here to cancel reply.

Or to contact Money Morning Customer Service, click here.

Your email address will not be published. Required fields are marked *

Some HTML is OK

A flurry of mergers-and-acquisition deals in the pharmaceutical and technology industries today (Monday) sparked a sharp market rally, snapping a three-day losing streak and giving stocks to their biggest gains in five weeks.

The pickup in merger activity bolstered arguments that mergers and acquisitions (M&A) are rebounding from the biggest slump in six years. It ignited a stock market rally that saw the Dow Jones Industrial Average jump 124.17 points, or 1.28% to close at 9,789.36. Meanwhile, the Standard & Poor's 500 Index surged 18.6 points, or 1.78% to 1,062.98 and the Nasdaq Composite Index rose 39.82 points, or 1.9%, to 2,130.74.

Any increase in dealmaking activity tends to move markets higher as it drives investors to speculate by buying shares of companies they think might be targeted for acquisition.

Drug-industry bellwether Johnson & Johnson (NYSE: JNJ) invested $442.7 million for a 18.1% stake in flu vaccine-maker Crucell (NASDAQ: CRXL). Meanwhile, Abbott Laboratories (NYSE: ABT), JNJ's smaller rival, purchased the pharmaceutical business of Belgium's Solvay SA (OTC ADR: SVYSY) for as much as $7 billion.

Technology heavyweight Xerox Corp. (NYSE: XRX) added to the frenzy by announcing it would pay $6.4 billion in cash and stock for outsourcing and information-services company Affiliated Computer Services Inc. (NYSE: ACS).

Finally, private equity firm American Securities purchased GenTek Inc (NASDAQ: GETI), a U.S. maker of specialty chemicals and engine components, for $411 million.

Sign up for SMS so you never miss special events, exclusive offers, and weekly bonus trades.

The merger activity buoyed the market after U.S. stocks fell last week on news of disappointing housing and durable-goods reports.

"We've seen a pickup in acquisitions and it's a very big plus," Hugh Johnson, who manages more than $1.6 billion as chairman of Albany, N.Y.-based Johnson Illington, told Bloomberg News. "It's always good news when you see money come into the market."

Johnson & Johnson and Abbott have been on buying sprees this year.  Abbott has been particularly active this month, buying medical device company Evalve Inc. for $410 million and Visiogen Inc. for $400 million.

Abbott's purchase of Solvay's drug unit was mainly aimed at shoring up its sagging prescription drug business with a number of new medicines in late stages of testing, sources familiar with the deal had earlier told Reuters. The deal also gives Abbott an important foothold in emerging markets in Asia and Europe.

Xerox, based in Norwalk, Conn., hopes to erase a drop in sales of large copier systems and printers for offices. The deal for ACS, an information technology consulting firm with large government contracts, is expected to triple Xerox's services revenue next year to an estimated $10 billion from 2008's $3.5 billion, according The Wall Street Journal.

Xerox's agreement comes on the heels of Dell Inc.'s (NASDAQ: DELL) purchase of information-technology service provider Perot Systems Corp. (NYSE: PER) for $3.9 billion. And that was preceded in April by Oracle Corp.'s (NASDAQ: ORCL) purchase of Sun Microsystems Inc. (NASDAQ: JAVA) for $7.4 billion.

The stage is set for a surge in mergers and acquisitions, according to data compiled by Credit Suisse Group AG (NYSE: CS) and Bloomberg.  U.S. companies are building cash reserves compared to the cost of interest on corporate bonds at the fastest rate in history, the research shows.  Firms are likely to increase cash flows to more than $1.5 trillion, the level the Commerce Department reported in July.

Additionally, in relation to corporate bond yields, cash holdings compared to share prices will jump to the highest levels in 20 years in 2010, the data shows.  The two biggest years for takeovers in history came after the previous high in 2005.

Further good news for the markets comes from another study conducted by the Investment Company Institute and Bloomberg, showing Americans are sitting on $3.5 trillion in cash. Investors have cash equal to 73% of S&P 500 companies' net assets, the study shows, even after draining money-market accounts by 11% this year. Investors only held 62% of net assets at the peak of the bull market in 2007.

The combination of increased merger activity and the giant cash horde held by investors is increasing money managers' confidence that the stock market rally will continue until at least the end of 2009.

"M&A can be a driver of gains for the market," Benoit de Broissia, an analyst at KBL Richelieu Gestion in Paris, told Bloomberg. "It illustrates that industrials have the cash to invest and consider valuations attractive. We can expect the M&A movement to continue."

News & Related Story Links:

  • Bloomberg:
    U.S. Stocks Climb on Takeovers; Affiliated Computer Surges
  • Money Morning:
    The U.S. Market for Deals Remains in a Deep Freeze
  • Reuters:
    Solvay sells drugs unit to Abbott for $6.6 billion
  • Money Morning:
    Dell Looks to Services in Perot Acquisition to Pick Up Slack for Slow PC Sales

Join the conversation. Click here to jump to comments…

Login
guest
guest
3 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
trackback
Is the United States on Sale?
13 years ago

[…] last Monday demonstrated, any increase in dealmaking activity tends to move markets higher: With the chance of windfall profits from a surprise buyout, investors […]

0
Reply
trackback
Two Reasons the Dow's Rally to 10,000 Will Keep Moving Ahead
13 years ago

[…] Kraft Foods Inc. (NYSE: KFT) has headlined a resurgence in M&A activity with its $16.7 billion bid for Cadbury PLC (NYSE ADR: CBY). Abbott Laboratories (NYSE: ABT), a […]

0
Reply
trackback
How to Find the Best Potential Profit Plays in the Resurgent M&A and IPO Markets
13 years ago

[…] related Money Morning news story that details the merger-and-acquisition deals yesterday (Monday), please click here. For more information on Louis Basenese's service, The Takeover Trader, please click […]

0
Reply


Latest News

June 7, 2023 • By Garrett Baldwin

(no title)

June 7, 2023 • By Garrett Baldwin

(no title)

June 7, 2023 • By Garrett Baldwin

A picture containing text, screenshot, font, line Description automatically generated
Postcards: This Value Strategy is Great for Finding Breakouts
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Profit Takeover Penny Hawk Trading Today Midday Momentum Pump Up the Close
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Night Trader Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Extreme Profit Hunters Profit Revolution Quantum Data Profits Live Trading Alliance Trade The Close Inside Money Trader Expiration Trader Flashpoint Trader Darknet Hyper Momentum Trader Alpha Accelerators Weekly Profit Cycles Brutus Alerts Resource Traders Alliance

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz